Literature DB >> 25490272

Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition?

Alexander Shifrin1, Virginia LiVolsi, Svetlana Shifrin-Douglas, Min Zheng, Brian Erler, Theodore Matulewicz, John Davis.   

Abstract

OBJECTIVE: Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other cancers may also occur with up to 10% of cancers from other sites showing parathyroid involvement at autopsy. Tumor-to-tumor metastases (metastatic spread to parathyroid neoplasm) from remote cancers to the parathyroid gland have been described.
METHODS: We did a PubMed literature review and analysis of our own experience of 392 consecutive parathyroidectomies.
RESULTS: Primary and secondary parathyroid malignancies can be grouped into three categories: primary parathyroid carcinoma (PPCa), spread of carcinoma into parathyroid glands by contiguous extension from the thyroid gland or other head and neck cancer, and metastatic disease to the parathyroid gland from distant cancers. Studies of tumor-to-tumor spread indicate a predilection of spread to endocrine tumors possibly because of the rich blood supply that is present in endocrine tumors. Two of our 392 parathyroidectomies (0.5%) had cancer: one metastatic (thymic neuroendocrine tumor) and another PPCa.
CONCLUSION: Metastatic disease to the parathyroid gland is poorly documented. When performing surgery for primary thyroid cancer, the search for parathyroid gland metastases is often overlooked because of the desire to preserve parathyroid function. Metastatic disease from other cancers to a benign parathyroid gland or to a parathyroid adenoma probably suggests a grave prognosis because it likely indicates widespread metastatic disease; however, isolated metastases to the parathyroid may occur. Although these lesions may be uncommon they may not be as rare as once thought.

Entities:  

Mesh:

Year:  2014        PMID: 25490272     DOI: 10.1210/jc.2014-2760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Hypercalcemia in metastatic breast cancer unrelated to skeletal metastasis.

Authors:  Heather Sigvaldason; Adebola Obayan; Ken von Kuster; K Alok Pathak
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

Review 2.  A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands.

Authors:  Vincent Cracolici; Raymon H Grogan; Madina Sukhanova; Jason X Cheng; Sandeep Gurbuxani; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2017-10-13

Review 3.  Update on parathyroid carcinoma.

Authors:  F Cetani; E Pardi; C Marcocci
Journal:  J Endocrinol Invest       Date:  2016-03-21       Impact factor: 4.256

4.  5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.

Authors:  Elham Barazeghi; Anthony J Gill; Stan Sidhu; Olov Norlén; Roberto Dina; F Fausto Palazzo; Per Hellman; Peter Stålberg; Gunnar Westin
Journal:  Clin Epigenetics       Date:  2016-03-12       Impact factor: 6.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.